Author:
Feldman Eva L.,Russell James W.,Löscher Wolfgang N.,Grisold Wolfgang,Meng Stefan
Publisher
Springer International Publishing
Reference34 articles.
1. Burns TM (2010) History of outcome measures for myasthenia gravis. Muscle Nerve 42:5–13
2. Di Stefano V, Lupica A, Rispoli MG et al (2020) Rituximab in AChR subtype of myasthenia gravis: systematic review. J Neurol Neurosurg Psychiatry 91:392–395
3. Gilhus NE, Owe JF, Hoff JM, Romi F, Skeie GO, Aarli JA (2011) Myasthenia gravis: a review of available treatment approaches. Autoimmune Dis 2011:847393
4. Gronseth GS, Barohn R, Narayanaswami P (2020) Practice advisory: Thymectomy for myasthenia gravis (practice parameter update). Neurology. https://doi.org/10.1212/WNL.0000000000009294
5. Guptill JT, Sanders DB (2010) Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis. Curr Opin Neurol 23:530–535